Form 4: NewAmsterdam Pharma Co CEO Buys Shares
Insider Transaction (Form 4)
Michael H. Davidson, Chief Executive Officer and a Director of NewAmsterdam Pharma Co N.V., purchased 10,000 shares of common stock on September 14, 2026 for $22.65 per share.
Summary
- Open-market purchase: acquired 10,000 Ordinary Shares at $22.65 ($226,500) on September 14, 2026; holds 792,923 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $226,500, committing personal capital to the stock.
Insider Transactions
Michael H. Davidson — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-14 | Open-market purchase | Ordinary Shares | 10,000 | $23 | $226.5K | 792,923 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-14 | Open-market purchase (10,000 shares) |
Keywords
insider transaction, Form 4, NAMS, NewAmsterdam Pharma Co N.V., bullish, Michael H. Davidson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.